Prosecution Insights
Last updated: April 19, 2026

Qanatpharma AG

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17274773 Use of Casein Kinase 1 Inhibitors For Treating Vascular Diseases RAMOS LEWIS, JOSMALEN MILAGROS 1621 Non-Final OA Mar 09, 2021
17274726 Use of CFTR Modulators For Treating Cerebrovascular Conditions DRAPER, LESLIE A ROYDS 1629 Final Rejection Mar 09, 2021

Managing Qanatpharma AG's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month